Indicated for: overactive bladder; urinary incontinence
Route of administration: oral
Substance: trospium (urinary antimuscarinic)
ATC: G04BD09 (Genito urinary system and sex hormones | Urologicals | Drugs for urinary frequency and incontinence)
Trospium is a medication used in the treatment of overactive bladder, a condition characterized by frequent urination, urinary urgency, and urinary incontinence. It is a muscarinic receptor antagonist that works by relaxing the bladder muscles and reducing involuntary contractions.
Trospium is administered orally in tablet form, with the dosage adjusted based on the severity of symptoms and the patient's response to treatment. It is important to take the medication on an empty stomach to maximize absorption.
Common side effects include dry mouth, constipation, nausea, and headache. In rare cases, allergic reactions or severe urinary retention may occur. Patients with pre-existing conditions such as narrow-angle glaucoma or renal impairment should use trospium with caution.
Trospium is an effective therapeutic option for managing overactive bladder symptoms, helping to improve patients' quality of life.